These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

544 related articles for article (PubMed ID: 31133010)

  • 1. CRKL regulates alternative splicing of cancer-related genes in cervical cancer samples and HeLa cell.
    Song Q; Yi F; Zhang Y; Jun Li DK; Wei Y; Yu H; Zhang Y
    BMC Cancer; 2019 May; 19(1):499. PubMed ID: 31133010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Tumor Suppressor SASH1 Interacts With the Signal Adaptor CRKL to Inhibit Epithelial-Mesenchymal Transition and Metastasis in Colorectal Cancer.
    Franke FC; Müller J; Abal M; Medina ED; Nitsche U; Weidmann H; Chardonnet S; Ninio E; Janssen KP
    Cell Mol Gastroenterol Hepatol; 2019; 7(1):33-53. PubMed ID: 30480076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibroblast Growth Requires CT10 Regulator of Kinase (Crk) and Crk-like (CrkL).
    Park T; Koptyra M; Curran T
    J Biol Chem; 2016 Dec; 291(51):26273-26290. PubMed ID: 27807028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-379 Suppresses Cervical Cancer Cell Proliferation and Invasion by Directly Targeting V-crk Avian Sarcoma Virus CT10 Oncogene Homolog-Like (CRKL).
    Shi X; Xiao X; Yuan N; Zhang S; Yuan F; Wang X
    Oncol Res; 2018 Aug; 26(7):987-996. PubMed ID: 29295725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The BCR/ABL oncogene alters interaction of the adapter proteins CRKL and CRK with cellular proteins.
    Uemura N; Salgia R; Li JL; Pisick E; Sattler M; Griffin JD
    Leukemia; 1997 Mar; 11(3):376-85. PubMed ID: 9067577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The proto-oncogene product p120CBL and the adaptor proteins CRKL and c-CRK link c-ABL, p190BCR/ABL and p210BCR/ABL to the phosphatidylinositol-3' kinase pathway.
    Sattler M; Salgia R; Okuda K; Uemura N; Durstin MA; Pisick E; Xu G; Li JL; Prasad KV; Griffin JD
    Oncogene; 1996 Feb; 12(4):839-46. PubMed ID: 8632906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adaptor proteins CRK and CRKL associate with the serine/threonine protein kinase GCKR promoting GCKR and SAPK activation.
    Shi CS; Tuscano J; Kehrl JH
    Blood; 2000 Feb; 95(3):776-82. PubMed ID: 10648385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative assessment of glioblastoma phenotypes in vitro establishes cell migration as a robust readout of Crk and CrkL activity.
    Park T; Large N; Curran T
    J Biol Chem; 2021; 296():100390. PubMed ID: 33561443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crk and CrkL present with different expression and significance in epithelial ovarian carcinoma.
    Wang J; Che YL; Li G; Liu B; Shen TM; Wang H; Linghu H
    Mol Carcinog; 2011 Jul; 50(7):506-15. PubMed ID: 21319228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Avian and 1918 Spanish influenza a virus NS1 proteins bind to Crk/CrkL Src homology 3 domains to activate host cell signaling.
    Heikkinen LS; Kazlauskas A; Melén K; Wagner R; Ziegler T; Julkunen I; Saksela K
    J Biol Chem; 2008 Feb; 283(9):5719-27. PubMed ID: 18165234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DDX41 regulates the expression and alternative splicing of genes involved in tumorigenesis and immune response.
    Qin K; Jian D; Xue Y; Cheng Y; Zhang P; Wei Y; Zhang J; Xiong H; Zhang Y; Yuan X
    Oncol Rep; 2021 Mar; 45(3):1213-1225. PubMed ID: 33650667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Knockdown of CkrL by shRNA deteriorates hypoxia/reoxygenation-induced H9C2 cardiomyocyte apoptosis and survival inhibition Via Bax and downregulation of P-Erk1/2.
    Zhang ZS; Yang DY; Fu YB; Zhang L; Zhao QP; Li G
    Cell Biochem Funct; 2015 Mar; 33(2):80-8. PubMed ID: 25703803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Essential roles of Crk and CrkL in fibroblast structure and motility.
    Park TJ; Curran T
    Oncogene; 2014 Oct; 33(43):5121-32. PubMed ID: 24166500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct roles for Crk adaptor isoforms in actin reorganization induced by extracellular signals.
    Antoku S; Mayer BJ
    J Cell Sci; 2009 Nov; 122(Pt 22):4228-38. PubMed ID: 19861495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. QKI-Regulated Alternative Splicing Events in Cervical Cancer: Pivotal Mechanism and Potential Therapeutic Strategy.
    Luo Y; Li Y; Ge P; Zhang K; Liu H; Jiang N
    DNA Cell Biol; 2021 Oct; 40(10):1261-1277. PubMed ID: 34551268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crk adaptor proteins act as key signaling integrators for breast tumorigenesis.
    Fathers KE; Bell ES; Rajadurai CV; Cory S; Zhao H; Mourskaia A; Zuo D; Madore J; Monast A; Mes-Masson AM; Grosset AA; Gaboury L; Hallet M; Siegel P; Park M
    Breast Cancer Res; 2012 May; 14(3):R74. PubMed ID: 22569336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SERBP1 affects the apoptotic level by regulating the expression and alternative splicing of cellular and metabolic process genes in HeLa cells.
    Zhou J; Chen W; He Q; Chen D; Li C; Jiang C; Ding Z; Qian Q
    PeerJ; 2022; 10():e14084. PubMed ID: 36213507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ATP5A1 Participates in Transcriptional and Posttranscriptional Regulation of Cancer-Associated Genes by Modulating Their Expression and Alternative Splicing Profiles in HeLa Cells.
    Song Ba Y; Wang Ma F; Wei Ma Y; Chen Ba D; Deng Ba G
    Technol Cancer Res Treat; 2021; 20():15330338211039126. PubMed ID: 34520292
    [No Abstract]   [Full Text] [Related]  

  • 19. miR-429-CRKL axis regulates clear cell renal cell carcinoma malignant progression through SOS1/MEK/ERK/MMP2/MMP9 pathway.
    Wang J; Wang C; Li Q; Guo C; Sun W; Zhao D; Jiang S; Hao L; Tian Y; Liu S; Sun MZ
    Biomed Pharmacother; 2020 Jul; 127():110215. PubMed ID: 32413671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel role for CRK adaptor proteins as essential components of SRC/FAK signaling for epithelial-mesenchymal transition and colorectal cancer aggressiveness.
    Franke FC; Slusarenko BO; Engleitner T; Johannes W; Laschinger M; Rad R; Nitsche U; Janssen KP
    Int J Cancer; 2020 Sep; 147(6):1715-1731. PubMed ID: 32147820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.